AR002905A1 - PHARMACEUTICAL COMPOSITIONS, SUITABLE TO DECREASE THE NUMBER OF CD8 + CELLS - Google Patents
PHARMACEUTICAL COMPOSITIONS, SUITABLE TO DECREASE THE NUMBER OF CD8 + CELLSInfo
- Publication number
- AR002905A1 AR002905A1 ARP960103677A AR10367796A AR002905A1 AR 002905 A1 AR002905 A1 AR 002905A1 AR P960103677 A ARP960103677 A AR P960103677A AR 10367796 A AR10367796 A AR 10367796A AR 002905 A1 AR002905 A1 AR 002905A1
- Authority
- AR
- Argentina
- Prior art keywords
- cells
- pharmaceutical compositions
- decrease
- compositions
- isopropoxyisoflavone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
Abstract
El presente invento se refiere a composiciones farmacéuticas, apropiadas para hacer disminuir la cantidad de células CD8+, que contienen en calidad decomponente activo la 7-isopropoxiisoflavona, en mezcla con excipientes inertes, sólidos o líquidos, y eventualmente con aditivos terapéuticos y sustanciasauxiliares. Estas composiciones se preparan por métodos conocidos y son apropiadas para tratar seres humanos o animales que se encuentran en unacondición en la que es deseable una supresión selectiva de linfocitos CD8+.The present invention relates to pharmaceutical compositions, suitable for reducing the amount of CD8 + cells, containing 7-isopropoxyisoflavone as an active component, in a mixture with inert solid or liquid excipients, and optionally with therapeutic additives and auxiliary substances. These compositions are prepared by known methods and are suitable for treating humans or animals in a condition where selective suppression of CD8 + lymphocytes is desirable.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9502198A HU9502198D0 (en) | 1995-07-21 | 1995-07-21 | Novel indication |
Publications (1)
Publication Number | Publication Date |
---|---|
AR002905A1 true AR002905A1 (en) | 1998-04-29 |
Family
ID=10987063
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP960103677A AR002905A1 (en) | 1995-07-21 | 1996-07-22 | PHARMACEUTICAL COMPOSITIONS, SUITABLE TO DECREASE THE NUMBER OF CD8 + CELLS |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0841915A1 (en) |
JP (1) | JP2001503371A (en) |
KR (1) | KR19990028933A (en) |
CN (1) | CN1191483A (en) |
AR (1) | AR002905A1 (en) |
AU (1) | AU6367096A (en) |
BG (1) | BG102182A (en) |
BR (1) | BR9610187A (en) |
CA (1) | CA2227421A1 (en) |
CZ (1) | CZ2798A3 (en) |
EA (1) | EA199800146A1 (en) |
EE (1) | EE9800020A (en) |
HR (1) | HRP960345A2 (en) |
HU (1) | HU9502198D0 (en) |
IL (1) | IL122751A0 (en) |
MX (1) | MX9800603A (en) |
NO (1) | NO980127D0 (en) |
PL (1) | PL324460A1 (en) |
SK (1) | SK3298A3 (en) |
WO (1) | WO1997003664A1 (en) |
YU (1) | YU42796A (en) |
ZA (1) | ZA966079B (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1241079B (en) * | 1990-03-23 | 1993-12-29 | Chiesi Farma Spa | PHARMACEUTICAL COMPOSITIONS CONTAINING IPRIFLAVONE, PROCEDURE FOR THEIR PREPARATION AND RELATED THERAPEUTIC USE |
HU212932B (en) * | 1993-08-02 | 1996-12-30 | Chinoin Gyogyszer Es Vegyeszet | Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition |
-
1995
- 1995-07-21 HU HU9502198A patent/HU9502198D0/en unknown
-
1996
- 1996-07-16 KR KR1019980700235A patent/KR19990028933A/en not_active Application Discontinuation
- 1996-07-16 MX MX9800603A patent/MX9800603A/en unknown
- 1996-07-16 JP JP50646497A patent/JP2001503371A/en active Pending
- 1996-07-16 EE EE9800020A patent/EE9800020A/en unknown
- 1996-07-16 CA CA002227421A patent/CA2227421A1/en not_active Abandoned
- 1996-07-16 CZ CZ9827A patent/CZ2798A3/en unknown
- 1996-07-16 EA EA199800146A patent/EA199800146A1/en unknown
- 1996-07-16 CN CN96195722A patent/CN1191483A/en active Pending
- 1996-07-16 SK SK32-98A patent/SK3298A3/en unknown
- 1996-07-16 EP EP96923004A patent/EP0841915A1/en not_active Withdrawn
- 1996-07-16 AU AU63670/96A patent/AU6367096A/en not_active Abandoned
- 1996-07-16 PL PL96324460A patent/PL324460A1/en unknown
- 1996-07-16 WO PCT/HU1996/000038 patent/WO1997003664A1/en not_active Application Discontinuation
- 1996-07-16 BR BR9610187A patent/BR9610187A/en not_active Application Discontinuation
- 1996-07-16 IL IL12275196A patent/IL122751A0/en unknown
- 1996-07-17 ZA ZA9606079A patent/ZA966079B/en unknown
- 1996-07-18 HR HRP9502198A patent/HRP960345A2/en not_active Application Discontinuation
- 1996-07-19 YU YU42796A patent/YU42796A/en unknown
- 1996-07-22 AR ARP960103677A patent/AR002905A1/en unknown
-
1998
- 1998-01-12 NO NO980127A patent/NO980127D0/en unknown
- 1998-01-14 BG BG102182A patent/BG102182A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO1997003664A8 (en) | 1999-08-05 |
CZ2798A3 (en) | 1998-06-17 |
JP2001503371A (en) | 2001-03-13 |
PL324460A1 (en) | 1998-05-25 |
EA199800146A1 (en) | 1998-08-27 |
NO980127L (en) | 1998-01-12 |
MX9800603A (en) | 1998-04-30 |
BR9610187A (en) | 1998-07-28 |
SK3298A3 (en) | 1998-07-08 |
EE9800020A (en) | 1998-08-17 |
ZA966079B (en) | 1998-01-19 |
BG102182A (en) | 1998-08-31 |
IL122751A0 (en) | 1998-08-16 |
HRP960345A2 (en) | 1998-02-28 |
HU9502198D0 (en) | 1995-09-28 |
EP0841915A1 (en) | 1998-05-20 |
AU6367096A (en) | 1997-02-18 |
WO1997003664A1 (en) | 1997-02-06 |
KR19990028933A (en) | 1999-04-15 |
YU42796A (en) | 1999-03-04 |
CN1191483A (en) | 1998-08-26 |
CA2227421A1 (en) | 1997-02-06 |
NO980127D0 (en) | 1998-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR960706344A (en) | MEANS AND METHOD FOR HORMONAL CONTRACEPTION AND / OR THE TREATMENT OF ACNE | |
TW283645B (en) | ||
CA2366702A1 (en) | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents | |
YU86001A (en) | Novel preparation and administration form comprising an acid-labile active compound | |
ES2185179T3 (en) | PREPARATION OF PHARMACEUTICAL COMPOSITIONS. | |
GR3036211T3 (en) | Taxane class derivative based pharmaceutical compositions | |
WO2001030802A3 (en) | Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies | |
IL157841A0 (en) | Activation of natural killer cells by adenosine a3 receptor agonists | |
KR970705553A (en) | Dihydrobenzofuran, and related compounds useful as anti-inflammatory drugs (DIHYDROBENZOFURAN AND RELATED COMPOUNDS USEFUL AS ANTI-INFLAMMATORY AGENTS) | |
DE69805983D1 (en) | COUGH-RESISTANT COMPOSITIONS CONTAINING THEOBROMINE | |
ES2134237T3 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING URSODESOXICOLICO ACID. | |
AR002905A1 (en) | PHARMACEUTICAL COMPOSITIONS, SUITABLE TO DECREASE THE NUMBER OF CD8 + CELLS | |
DK1509523T3 (en) | Triazaspiro compounds useful for treating or preventing pain | |
ATE173624T1 (en) | SYNERGISTIC PHARMACEUTICAL COMPOSITIONS CONTAINING TRIAMCINOLONEACETONIDE AND HALCINONIDE | |
ES2172179T3 (en) | PHARMACEUTICAL COMPOSITIONS OF CONTROLLED RELEASE CONTAINING THIAGABINE. | |
ATE24111T1 (en) | MIXTURE CONTAINING A CENTRAL ANALGESIC AND VITAMINS B12 OR ONE OF ITS ANALOGUES AS ACTIVE INGREDIENTS. | |
ES2162022T3 (en) | TIOL DERIVATIVES WITH INHIBITING ACTIVITY OF METALOPEPTIDASA. | |
GEP20053581B (en) | Pharmaceutical Composition and Method for Preparation Thereof | |
AR027038A1 (en) | METHOD AND COMPOSITION FOR PAIN TREATMENT | |
CO4750838A1 (en) | METHOD FOR THE TREATMENT OF ADVERSE INFLAMMATORY REACTIONS AND ADMINISTERED ANTI-INFLAMMATORY COMPOSITION | |
CA2216700A1 (en) | Synergistic pharmaceutical compositions containing triamcinolone acetonide and halcinonide | |
GT199500028A (en) | PROCEDURE TO PREPARE A SELECTIVE HERBICIDE SOLUTION | |
KR950005312A (en) | Pharmaceutical composition for treating liver disease and improving liver function |